Begin main content

Pharmaceutical Reviews Update 7

April 17, 2019
See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised following a request for reconsideration by manufacturers...

Call for Patient Input and Clinical Experts: Cuvposa

April 11, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Cuvposa Generic name glycopyrrolate Manufacturer MEDEXUS Pharmaceuticals, Inc. Indication(s) chronic severe drooling, neurologic (pediatric) Project Number SR0613-000 Call for patient input 2019-04-11 Patient input deadline 2019-06-03 Submit patient input Submit...

Call for Patient Input and Clinical Experts: Aimovig

April 4, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Aimovig Generic name erenumab Manufacturer Novartis Pharmaceuticals Canada Inc. Indication(s) Migraine Project Number SR0578-000 Call for patient input 2019-04-04 Patient input deadline 2019-05-27 Submit patient input Submit Register as Clinical Expert Register...

Call for Patient Input and Clinical Experts: Lokelma

April 4, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Lokelma Generic name sodium zirconium cyclosilicate Manufacturer AstraZeneca Canada Inc. Indication(s) Hyperkalemia, adults Project Number SR0612-000 Call for patient input 2019-04-04 Patient input deadline 2019-05-27 Submit patient input Submit Register as Cli...